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ODELL and Burt's work (1949) on the beta glucuronidase content of vaginal
fluid has stimulated considerable interest in the use of enzymes as definitive tests
for the diagnosis ofcarcinoma ofthe cervix. Bonham and Gibbs (1962) published
their results on 6-phosphogluconate dehydrogenase content of the vaginal fluid.
In the course of a series to evaluate the use of this enzyme other enzymes were
studied.
Since this work was part of an evaluation of 6-phosphogluconate dehydro-
genase, the study of these enzymes has confined itself solely to their application
under the conditions used for 6-phosphogluconate dehydrogenase. It must be
remembered that such conditions may not be suitable for these enzymes and result
in a poor recovery. Since one is studying the effects offreezing drying in releasing
intracellular enzymes, the effect of freeze drying on a pure enzyme is not a satis-
factory estimate of the recoveries.
It was felt that the situation in the posterior fornix was comparable to that
occurring with effusions, where a malignant epithelium is in contact with an
exudate or secretion. In general the enzymes chosen for study were those which
had been shown to be raised in malignant effusions, or else enzymes which had
been shown to be raised in neoplastic materials, or enzymes which had been found
to be raised in the serum from cases with neoplasia.
Lactic dehydrogenase
Wroblewski and Wroblewski (1958) and Fleisher (1959) showed that the lactic
dehydrogenase activity of malignant pleural or ascitic fluid was raised above
serum activities. Horrocks, King, Waind and Ward (1962) confirmed this
finding, but also pointed out that the enzyme was raised in inflammatory effusions.
Barrett and Gibson (1964) have shown that the isoenzyme 5 of lactic dehydro-
genase is raised in breast tissue and the higher the tumour grading the more
isoenzyme could be detected. Latner (1964) confirmed similar findings in cases
of carcinoma of the cervix.
In patients with carcinomatosis, lactic dehydrogenase is increased in between
40% and 50% (Hill and Levi, 1954; Bierman et al., 1957).
Aldolase
Sibley and Lehninger (1949) and White (1958) found that the serum aldolase
was increased in 20% of cases with carcinomatosis. Warburg and Christian
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(1943) found that in rats with Jensen sarcoma the serum aldolase was increased;
the increase only occurred if the tumour were large, then it was proportional to
size. Sibley and Lehninger (1949) showed that the serum aldolase fell after
removal of the neoplasm.
Glutamic oxaloacetic tran8aminase
Unless there are secondary deposits in the liver, the serum oxaloacetic transa-
minase is rarely found to be elevated in patients with carcinomatosis. In work
on animals with the Morris hepatoma 5231, Dyer et al. (1961) showed that the
glutamic oxaloacetic transaminase tended to be raised. This elevation fell when
the tumour was removed. In a more rapidly growing hepatoma, the tumour
content ofglutamic oxaloacetic transaminase was lower than in the slowly growing
Morris hepatoma.
MATERIALS
Samples were obtained from women attending the Well Women's Clinic at
St. Bartholomew's Hospital and the Gynaecological Departments of that hospital,
the Luton and Dunstable Hospital and Bedford General Hospital. In this paper
the women were only classified as normal if there were no detectable cytological
or gynaecological lesion.
In the discussion of the enzyme results the following terms are used:
1. Detectable activity. This is used to mean an activity being present, but
not to such a level as to suggest malignancy.
2. Elevated activity; this means an activity above the diagnostic level.
METHOD
Samples were obtained in a manner similar to that of Bonham and Gibbs
(1962); 6-phosphogluconate dehydrogenase was assayed by the methods of
Glock and McLean (1953).
Lactic dehydrogenase
The assay ofthe lactic dehydrogenase content was a modification ofthe method
of Wroblewski and LaDue (1955). The reagents were all obtained in a kit from
the Boehringer Corporation. The assay was scaled down to be suitable for
vaginal fluid.
Calculation:
The results were expressed for convenience in Wroblewski units.
1000 X . X -X - units per gram dry weight 0.001 y
where x the change in optical density per minute, y - the mg. dry weight of
vaginal fluid in the reaction mixture.
Glutamic oxaloacetic transarminase
The method used was a modification of the ultraviolet assay described by
Karmen, Wroblewski and LaDue (1955). The reagents were all obtained in a
kit from the Boehringer Corporation.
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Calculation:
Wroblewski units were used. If x = the recorded change per minute, and
y - the mg. of vaginal debris present in the reaction mixture, the activity per
gram is given by the following formula
x 1000 units per gram = x y
Aldolase
A modification of the ultraviolet method of Bruns (1954) was used. In this
assay the enzyme activity is determined by linking the reaction to the ultraviolet
by the use of triose phosphate isomerase and glycerophosphate dehydrogenase.
Bruns unit is defined as that amount of enzyme activity which removed the
0-0446 ,umoles of fructosel-6 diphosphate per hour at 250 C. In this assay, 0-892
,tmoles ofnicotinadenine dinucleotide are reduced during the conversion of 0.0446
,umoles of fructose 1-6 diphosphate to triose phosphate.
The overall reaction is
fructosel-6 diphosphate + 2 nicotinamide adenine dinucleotide (reduced)
-*2 glycerol-l-phosphate + 2 nicotinamide adenine dinucleotide.
In a 3 ml assay the optical extinction of 0*0892 ,tmoles nicotinamide adenine
dinucleotide phosphate reduced form is 0.18732 optical density units. Thus a
change of optical density of 0-18732 optical density units in 1 hour equals 1 Bruns
unit.
If x the change in 20 minutes, and y _ the mg. of vaginal debris in the assay
mixture, the Bruns unit per gram will be given by the following formula:
Bruns unit per gram =0187 x 3 x
1
Glucose-6-phosphate dehydrogenase
Glock and McLean (1953) described two methods for the assay of glucose-
6-phosphate dehydrogenase. One ofthe methods has the advantage that it allows
the comparison of the two enzymes at pH 7-6. The assay was used. Reagents
and materials are modified to suit this assay in the vaginal fluid.
0.5 ml. 01 molar magnesium chloride
0 5 ml. 0.25 molar glycylglycine buffer, pH 7-6
0 2 ml. of a solution containing
0-2 molar trisodium 6 phosphogluconate
0-2 molar glucose-6-phosphate sodium salt
041 ml. vaginal fluid supernatent
The reaction is started by the addition of0-2 ml. nicotinamide adenine dinucleo-
tide phosphate 10 mg./ml. The blank has 0.2 ml. of distilled water instead of
the co-enzyme.
The second cell consists of the same reaction mixture, but contains only
6-phosphogluconate. The difference between the activity from cell one and two
gives a measure of the activity due to glucose-6-phosphate dehydrogenase.
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RESULTS
(a) Lactic dehydrogenase
Fig. 1 shows the results in 25 normal women compared with 6-phospho-
gluconate dehydrogenase in the same specimen. 80% (20) of the vaginal samples
gave lactic dehydrogenase activities below 30,000 units per gram dry weight.
16% of samples (4 cases) gave elevated levels of 6-phosphogluconate dehydro-
genase, in a previous paper describing a larger series, 588% of normal women had
elevated levels (Muir and Canti, 1966).
TABLE I.-Vaginal fluid activities of lactic dehydrogenase and 6-phosphogluconate
dehydrogenase in menstruation
6-phosphogluconate Lactic
dehydrogenase dehydrogenase
Day units per gram units per gram
2 101 . 20,000
4 81-5 46,000
2 105 70,000
5 199 68,000
102 30,000
3 323 . 65,000
Table I gives the figure in menstruating women. Both enzymes are elevated
in menstruation, but the lactic dehydrogenase does not appear so markedly
elevated. Two of 6 cases had a lactic dehydrogenase level of 30,000 units per
gram dry weight or less.
TABLE II. A comparison of lactic dehydrogenase and 6-phosphogluconate
dehydrogenase in benign gynaecological conditions
No detect- Detect- Per- Per-
Number of able able cent- Over cent-
Enzyme cases activity activity age level age
6-phospho- 43 13 30 69-8 21 48.8
gluconate
dehydrogenase
Lactic 43 6 . 37 86. 20. 46-5
dehydrogenase
In benign gynaecological lesions (Table II) both enzymes give similar incidence
of elevated enzyme results. From Fig. 1 it is apparant that lactic dehydrogenase
is more often present in normal vaginal fluid than 6-phosphogluconate dehydro-
genase. This difference between the two enzymes would explain the higher
incidence of detectable lactic dehydrogenase in cases with gynaecological lesions.
In cases of trichomonas vaginalis both enzymes were affected to a similar
degree. There was no sample without elevated enzyme levels. From Table II
it is apparent that while it is possible to have an elevated lactic dehydrogenase
without an elevated 6-phosphogluconate dehydrogenase, the other distribution
is more common.
Table III gives an analysis according to the different types of carcinoma. In
carcinoma in situ, invasive cervical carcinoma, and carcinoma of the body, the
two enzymes give similar results. 6-phosphogluconate dehydrogenase activity
gives a better correlation with carcinoma of the ovary than lactic dehydrogenase
If the two enzymes had been together, 3 of 4 carcinomas in situ would have been
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FIG. 1.-Lactic dehydrogenase levels in normal women.
TABLE III.-A comparison of the vaginal fluid activities of lactic dehydrogenase
and 6-phosphogluconate dehydrogenase in varying gynaecological malignancies
Malignancy
Carcinoma
in 8itU
Carcinoma of
the cervix
Carcinoma of
corpus uteri
Carcinoma
of ovary
Number Enzyme
4 . 6PGD
LDH
14 6PGD
LDH
6 . 6PGD
LDH
4 . 6PGD
LDH
No activity Activity Diagnostic
detected detected activity
1
0
0
0
0
0
1
0
3
4
14
14
6
6
3
4
2
2
14
13
4
4
2
1
detected, and 5 of 6 body carcinomas. No difference would have occurred with
ovarian carcinomas.
(b) Clutamic oxaloacetic transaminase
Vaginalfluidoxaloacetictransaminase was studiedin63 womenwith noevidence
ofmalignancy and in 20 women with malignant disease ofthe genital tract.
Fig. 2 shows the results in normal women. Twenty-one normal women were
studied. Two of 21 women had 6-phosphogluconate dehydrogenase above 80
units per gram dry weight. Since only 2 women (5%) had glutamic oxaloacetic
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transaminase of more than 2000 units per gram dry weight, it was decided that
2000 u/g. dry weight should be the upper limit for the normal range.
Fig. 3 shows the results in 42 women with gynaecological lesions. Nineteen
had glutamicoxaloacetictransaminase of 2000 unitsper gram dry weight or below,
while 21 women had results of less than 80 units per gram dry weight with
6-phosphogluconate dehydrogenase.
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Fie. 2.- Oxaloacetic transaminase in normal women
TABLE IV.-A Comparison of 6-Phosphogluconate Dehydrogenase and Glutamic
Oxaloacetic Transaminase in the Vaginal Fluid ofGynaecological malignancy
Malignancy
Carcinoma
in situ
Carcinoma
of cervix
Carcinoma
of body
Carcinoma
of ovary
Number Enzyme
1 . 6PGD
GOT
14 . 6PGD .
GOT
3 . 6PGD .
GOT
2 6PGD .
GOT
No activity Activity Diagnostic
detected detected activity
1
1
1
1
1
14
13
3
11
11
1
1 I 3
1
1
Table IV shows the results in 20 cases of gynaecological carcinoma. While
5 cases were not detected with 6-phosphogluconate dehydrogenase, 7 were not
detected with glutamic oxaloacetic transaminase. In this small series the two
enzymes gave similarresults, though 6-phosphogluconate dehydrogenase correlated
better with malignancy
21
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FIG. 3.-Oxaloacetic transaminase levels in women
with gynaecological lesions.
(c) Aldolase
There were 21 normal women in this group. Fig. 4 shows the results. Ofthe
21 women, only one womanhad alevel ofmore than 2,500units, thus 95% of these
women fell under 2,500 units per gram dry weight. It was decided that this level
should be regarded as the upper limit of normal. Table V shows the results in
menstruation. In menstruation the vaginal fluid aldolase activity is not as
markedly increased as the 6-phosphogluconate dehydrogenase activity.
TABLE V.-Vaginal Fluid Activities ofAldolase and 6-Phosphogluconate
Dehydrogenase During Menstruation
6-phosphogluconate
dehydrogenase Aldolase
Day units per gram units per gram
4 . 81*5 . 194
2 105 . 705
3 . 408 . 960
4 . 551 . 1,730
5 . 599 . 4,160
Fig. 5 shows the results in a group of women with gynaecological lesions.
Of 43 women, 25 have 6-phosphogluconate dehydrogenase activities greater than
80 units per gram dry weight, while 20 had vaginal aldolase contents ofmore than
2,500 units per gram dry weight.
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In 3 cases with trichomonas vaginalis infection, the vaginal aldolase activity
was increased in only one, while the vaginal 6-phosphogluconate dehydrogenase
was increased in all cases. It appears that the vaginal fluid aldolase contents
gives a slightly lower incidence of false positive results than 6-phosphoglu-
conate dehydrogenase.
The results in cases of malignancy are given in Table VI. Of 4 samples from
cases of carcinoma in situ, both enzymes failed to detect two cases. In estab-
lished invasive carcinoma ofthe cervix, uterus, and ovary, the 6-phosphogluconate
dehydrogenase activity correlated more closely with malignancy.
TABLE VI.-A Comparison of 6-phosphogluconate dehydrogenase and Aldolase
in the Vaginal Fluid ofGynaecological Malignancy
No activity Activity Diagnostic
Malignancy Number Enzyme detected detected activity
Carcinoma . 4 . 6PGD . 1 . 3 . 2
in situ . Aldolase . - . 4 . 2
Carcinoma . 12 6PGD . . 12 . 10
of cervix
and vagina . Aldolase . . 12 . 8
Carcinoma . 6 . 6PGD . - 6 . 5
of corpus . Aldolase . 6 . 4
Carcinoma 4 6PGD . 1 . 3 . 3
of ovary . Aldolase . 1 . 3 . 1
(d) Glucose-6-phosphate dehydrogenase
The results on 23 samples are given in Table VII. There were 12 samples
from malignant or pre-malignancy conditions. Among these 12 cases there were
8 established carcinomas, in 6 of which glucose-6-phosphate dehydrogenase was
elevated to an equal or greater extent than 6-phosphogluconate dehydrogenase
at pH 7-6 and pH 90.
In 11 samples from patients with benign conditions are shown only 3 cases
in which glucose-6-phosphate dehydrogenase was higher than 6-phosphogluconate
dehydrogenase.
There is no evidence that the use of glucose-6-phosphate dehydrogenase
increases diagnostic efficiency. One sample from an established carcinoma was
missed by 6-phosphogluconate dehydrogenase, while 3 established carcinomas
were missed by glucose-6-phosphate dehydrogenase using a similar level ofactivity
to distinguish benign and malignant conditions.
(e) Simultaneous multiple enzyme studies
In a certain number ofsamples more than 2 enzymes were studied.
Nor?mal women.-In 6 samples from normal women, glutamic oxaloacetic
transaminase and 6-phosphogluconate dehydrogenase, lactic dehydrogenase, and
aldolase activities were estimated. In a further 10 cases the oxaloacetic trans-
aminase, the 6-phosphogluconate dehydrogenase and the aldolase were studied.
In 3samples the activities of6-phosphogluconate,lacticdehydrogenaseandaldolase
were also studied. In only 1 sample was the 6-phosphogluconate dehydrogenase
and the other enzymes elevated . In 2 ofthese samples, the glutamic oxaloacetic
transaminase was elevated by itself.
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TABLE VII.-A Comparison of GlUcose-6-phosphate Dehydrogenase and
6-Phosphogluconate Dehydrogenase Activities in Benign and Malignant Conditions
Clinical Condition
Carcinoma of the cervix
a) before irradiation
b) post irradiation
Carcinoma of cervix IV
Carcinoma of cervix
Carcinoma of cervix
Carcinoma of vagina
Pelvic carcinomatosis
Carcinoma of body
Chorionepithelioma
Dysplasia
Dysplasia
Trichomonas vaginalis
Fibroids and cervical polyp
Postmenopausal bleeding
Low oestrogen level
Low oestrogen level
Chronic cervicitis
Erosion
Postmenopausal bleeding
Post abortion .
Post cone biopsy
Chronic cervicitis
Enzyme activity in units per gram dry weight
r- -A-
glucose-6- 6-phospho- 6-phospho-
phosphate gluconate gluconate
dehydrogenase dehydrogenase dehydrogenase
pH 7-6 pH 7-6 pH 9 0
62-2 26-3 16-7
555 421 167
3020
373
76
44-1
468
870
123
789
101
105
4*8
* 263
38
24*0
1446
359
114
53
33
207
1770
278
498
99.4
343
522
187
1095
263
153
nil
115
206
52-6
655
230
173
273
192
512
2300
388
709
114
402
504
119
861
430
97*1
38-2
86*1
201
49
742
259
205
340
177
505
Women with gynaecological lesions.-In 17 samples the 6-phosphogluconate
dehydrogenase, the aldolase, glutamic oxaloacetic transaminase and lactic dehy-
drogenase were all studied. In 11 samples, 6 phosphogluconate, glutamic oxalo-
acetic transaminase and aldolase were studied. In the remaining six cases 6
phosphogluconate dehydrogenase, lactic dehydrogenase and glutamic oxaloacetic
transaminase activities were also studied. In only 1 case were any other enzymes
elevated when the 6-phosphogluconate dehydrogenase was not. In 18 of 34
samples the 6-phosphogluconate dehydrogenase was elevated. Similar results
were found with the glutamic oxaloacetic transaminase. In 11 of 23 samples the
lactic dehydrogenase was elevated while in 12 of28 cases the aldolase was elevated.
Each enzyme gave a false positive rate of 48% for lactic dehydrogenase, 43% for
aldolase, 53% for glutamic oxaloacetic transaminase and 6-phosphogluconate
dehydrogenase. It was also found that if samples had an elevated 6-phospho-
gluconate dehydrogenase, in 58% of these samples the lactic dehydrogenase was
also elevated, while in 55% of the same sampletheglutamic oxaloacetic transami-
nase was elevated. In 53% the aldolase was elevated. If the lactic dehydro-
genase activity in the samples was raised, in 54% ofthese samples the 6-phospho-
gluconate dehydrogenase was elevated, in 53% the glutamic oxaloacetic transa-
minase, and in 54% the aldolase. If the glutamic oxaloacetic transaminase was
elevated the 6-phosphogluconate dehydrogenase was elevated in 55°%,; the lactic
dehydrogenase in 54% and the aldolase in 57%. When the aldolase was elevated
the 6-phosphogluconate dehydrogenase was also elevated in 53%; the glutamic
oxaloacetic transaminase in 57% and the lactic dehydrogenase in 55%. Table
VIII summarises these results. From Table VIII it appears that in benign
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TABLE VIII.-Correlation of Multiple Enzyme Studies in Benign Conditions
Associated enzyme elevated with number
of samples which might have shown elevation
IF
x
Enzyme
elevated
6-phospho-
gluconate
dehydrogenase
Lactic
dehydrogenase
Oxaloacetic
transaminase
Aldolase
Number of
sample
18
11
18
19
Lactic
dehydrogenase
7 of 12
58%
Aldolase
8 of 15
53%
- 5 od 9
45%
9 of 14 8 of 14
64% 57%
5 of 9
55%
conditions the lactic dehydrogenase and the glutamic oxaloacetic transaminase
activities seemed to correlate together while the 6-phosphogluconate dehydro-
genase and the aldolase appear also to correlate with each other.
TABLE IX.-Mixed Enzymes in the Vaginal Fluid of Women with Carcinoma
of the Cervix
Enzyme units per gram dry weight
- ~~~~~A- I
6-phosphogluconate
dehydrogenase
1920
2020
565
1830
1280
2040
537
225
394
28-8
2480
1560
Serum glutamic
oxaloacetic
transaminase
10,000
3,000
2,200
2.800
5,400
7,000
6,200
3,000
800
400
2,400
Women with gynaecological malignancies.-In 11 samples ofinvasive carcinoma
ofthe cervix, the 4 enzymes were studied together, and in one case the oxaloacetic
transaminase was not assayed. The results are shown in Table IX. In one
sample the 6-phosphogluconate dehydrogenase was not elevated, but neither
were any of the other enzymes. In Table X the results are summarised.
In Table XI the results of multiple enzymes in carcinoma of the corpus uteri
and ovary are given. In 3 samples from carcinoma uteri 4 enzymes were studied
and in 2 samples, 3 enzymes. In only one case was the aldolase diagnostic when
the 6-phosphogluconate dehydrogenase was not. In one case oxaloacetic trans-
aminase was the only elevated enzyme. Ifthe 6-phosphogluconate dehydrogenase
was elevated, the other enzymes were generally elevated.
Had all 4 enzymes been used, the 5 cases would have been detected. When
only the 6-phosphogluconate dehydrogenase, lactic dehydrogenase, and aldolase
were used, 4 cases were diagnosed. Individually, of these 3 enzymes, each did
as well as the other.
Oxaloacetic
transaminase
10 of 18
55%
7 of 11
63%
8 of 14
57%
6-phospho-
gluconate
dehydrogenase
6 of 11
54%
10 of 18
55%
8 of 12
67%
Lactic
dehydrogenase
70,000
330,000
60,000
260,000
100,000
95,000
39,000
80,000
42,000
3,000
150,000
700,000
Aldolase
22,720
13,120
5,410
7,540
1,920
6,276
9,410
6,009
18,200
1,185
11,610
1,845
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TABLE X.-Results ofMultiple Enzymes in Invasive
Carcinoma ofthe Cervix
Note: The table compares the number of elevations of one enzyme with the
number ofpossible elevations it could have in association with another
enzyme.
Associated enzymes elevation
Number Lactic Oxalo- 6-phospho-
elevated de- acetic gluconate
Enzyme out of hydro- transa- dehydro-
elevated total genase minase Aldolase genase
6-phospho- . 11 of 12 11 of 11 9 of 10 9 of 11 -
gluconate
dehydrogenase
Lactic . of 12 - 9 of 10 9 of 11 11 of 11
dehydrogenase
Oxaloacetic 9 of 11 9 of 9 - 8 of 9 11 of 11
transaminase
Aldolase . 1of 12 10 of 10 9 of 10 10 of 10
TABLE XI.-MixedEnzymes in the Vaginal Fluid of Women with Carcinoma
ofthe Body and with Carcinoma of the Ovary
Enzyme units per gram dry weight
Serum glutamic
6-phosphogluconate oxaloacetic Lactic
dehydrogenase transaminase dehydrogenase Aldolase
Carcinoma of the body
216 36,000 60,000 1,959
19-2 800 10,000 4,030
31-2 7,000 30,000 320
763 48,000 5,860
990 35,000 7,510
Carcinoma of the ovary
nil nil 2,500 nil
1459 1,400 13,790
341 - 32,500 2,310
158 - 8,000 1,470
In 4 samples from carcinoma of the ovary, no advantage was gained by using
more than one enzyme. Three out of four cases were associated with elevated
6-phosphogluconate dehydrogenase, while one case was detected by lactic dehydro-
genase, and one by aldolase.
DISCUSSION
In this series the enzymes have all been compared with 6-phosphogluconate
dehydrogenase. The number of enzymes studied depends on the amount of
vaginalfluid studied. In general it may be said that women with a gynaecological
lesion tend to have a higher secretion ofvaginal fluid, thus in this series there will
tend to be a greater number of cases with elevated levels unassociated with
carcinoma. It is thought that this increased secretion is caused by an inflam-
matory exudate.
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Results with lactic dehydrogenase
Normal women.-Lactic dehydrogenase gives a slightly higher incidence of
abnormal or elevated activities in this group of women than 6-phosphogluconate
dehydrogenase, but a very much higher incidence of detectable enzyme than
6-phosphogluconate dehydrogenase. Unlike 6-phosphogluconate dehydrogenase,
this enzyme appears to be rarely absent from the vagina. From Fig. 1 it would
appearthat in normal women ifthe 6-phosphogluconate dehydrogenase is elevated,
then the activity of lactic deydrogenase is related to the amount of 6-phospho-
gluconate dehydrogenase.
Benign gynaecological lesions.-One can have a moderate amount of lactic
dehydrogenase in the absence of 6-phosphogluconate dehydrogenase in women
with benign gynaecological lesions. If there is an elevated 6-phosphogluconate
dehydrogenase, lactic dehydrogenase tends to be higher than in those with low
6-phosphogluconate dehydrogenase levels. In these samples the two enzymes
gave a similar number ofelevated enzyme levels in the benign cases.
Gynaecological malignancy.-Lactic dehydrogenase gave similar results to
6-phosphogluconate dehydrogenase. In these cases there was a closer relationship
between the amount of 6-phosphogluconate dehydrogenase and the amount of
lactic dehydrogenase detected. It thus appears that little is gained by the use
of lactic dehydrogenase instead of 6-phosphogluconate dehydrogenase. In
Table V the results for the two enzymes are shown. It was found that 3 out of 4
carcinomas in situ would have been detected when both were used; there would
have been no difference in invasive cervical carcinoma but 5 out of 6 carcinomas
of the corpus uteri would have been detected. No difference would have been
found with ovarian carcinomas. It is possible that the combination of6-phospho-
gluconate dehydrogenase with lactic dehydrogenase might be an advantage.
Results with glutamic oxaloacetic transaminase
In normal women the oxaloacetic transaminase gave similar results to the
6-phosphogluconate dehydrogenase. In cases with benign gynaecological lesions
the oxaloacetic transaminase gave a slightly higher incidence of false positive.
In 20 cases of malignancy, one obtained largely similar results. Unfortunately
only one case of carcinoma in situ was studied.
Res.ults with aldolase
Using 2,500 units per gram dry weight, only 1 of 21 normal cases had levels
above 2,500, thus 95% of normal cases came below this level. Almost all the
women had detectable aldolase values in their vaginal fluids. In this way it
would appear to be similar to lactic dehydrogenase. In cases with gynaecological
lesions, aldolase gave a lower incidence ofelevated levels than 6-phosphogluconate
dehydrogenase. It did not seem to be so markedly affected by the trichomonas
vaginalis infection or menstruation as 6-phosphogluconate dehydrogenase. In
malignancy the results are not as reliable as those with 6-phosphogluconate
dehydrogenase.
Results with glucose-6-phosphate dehydrogenase
In established carcinoma it was more common for the vaginal fluid glucose-
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activity of 6-phosphogluconate dehydrogenase. This finding is in agreement with
the work on hepatoma tissue. Unfortunately this finding is not invariable and
appears to be ofno diagnostic value.
In eight established carcinomas there were only 2 cases in which the glucose-
6-phosphate dehydrogenase was not elevated to a greater extent than the 6-phos-
phogluconate dehydrogenase activity. In both these cases 6-phosphogluconate
activities were diagnostic. In a third case both enzymes were not diagnostic.
Little seems to be gained by the estimation ofboth dehydrogenases.
In benign conditions the situation was reversed. In only 3 cases was
glucose-6-phosphate dehydrogenase elevated to a greater degree than the 6-phos-
phogluconate dehydrogenase. The most use the simultaneous study of the two
dehydrogenases might have would be to eliminate some of the false positive
results.
Results in multiple enzyme studies
In normal women it was found that the 6-phosphogluconate dehydrogenase
activity correlates with the other enzyme activity. If this enzyme is not raised
it is very rare for any of the others to be raised. In cases with gynaecological
lesions the enzyme activities parallel each other. The use ofthe group ofenzymes
did not enable one to eliminate any false positive results.
It appears that in these carcinomas, the corpus uteri is the only situation in
which multiple studies were ofdiagnostic advantage.
CONCLUSION
It appears that the use of any ofthese enzymes by themselves did not improve
on 6-phosphogluconate dehydrogenase. The use of a multiple screen by the four
enzymes (lactic dehydrogenase, glutamic oxaloacetic transaminase, 6-phospho-
gluconate dehydrogenase, and aldolase) did not significantly improve on the sole
use of 6-phosphogluconate dehydrogenase. It is possible that a combination
of 6-phosphogluconate dehydrogenase and lactic dehydrogenase might prove
a successful combination.
6-phosphogluconate dehydrogenase has the advantage of not being present
in samples of vaginal fluid from normal women. Thus a clear cut distinction can
be more easily made. It still has the disadvantage of missing certain cases of
carcinoma in situ.
SUMMARY
Multiple enzyme studies have been made of the vaginal fluid in benign and
malignant disease of the female genital tract. The results were compared with
6-phosphogluconate dehydrogenase. It appears that none of these enzymes
improved on 6-phosphogluconate dehydrogenase.
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